Blackstone Inc
RVMD icon

Blackstone Inc’s Revolution Medicines RVMD Stock Holding History

Blackstone Inc’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.8M Buy
9,635
+6,096
+172% +$890K 0.01% 185
2026
Q1 		$344K Buy
+3,539
New +$357K ﹤0.01% 332
2024
Q2 		– Sell
-37,197
Closed -$1.2M – 193
2024
Q1 		$1.2M Hold
37,197
– – ﹤0.01% 135
2023
Q4 		$1.07M Hold
37,197
– – ﹤0.01% 111
2023
Q3 		$1.03M Hold
37,197
– – ﹤0.01% 121
2023
Q2 		$995K Hold
37,197
– – ﹤0.01% 124
2023
Q1 		$806K Buy
37,197
+6,081
+20% +$150K ﹤0.01% 130
2022
Q4 		$741K Buy
31,116
+6,428
+26% +$137K ﹤0.01% 112
2022
Q3 		$487K Buy
24,688
+7,500
+44% +$165K ﹤0.01% 157
2022
Q2 		$335K Hold
17,188
– – ﹤0.01% 199
2022
Q1 		$438K Hold
17,188
– – ﹤0.01% 200
2021
Q4 		$433K Hold
17,188
– – ﹤0.01% 352
2021
Q3 		$473K Sell
17,188
-399,441
-96% -$11.6M ﹤0.01% 411
2021
Q2 		$13.2M Buy
+416,629
New +$14.5M 0.03% 125

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Blackstone Inc's RVMD Position: Q2 2026 in Review

Blackstone Inc increased its Revolution Medicines (RVMD) stake by 172% in Q2 2026, buying an estimated $890K and bringing the position to 9,635 shares worth $1.8M. The position accounts for 0.01% of the portfolio, ranked #185.

Blackstone Inc first reported a position in RVMD in Q2 2021 and has held it in 14 quarters since. The position peaked at $13.2M in Q2 2021. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Blackstone Inc held 9,635 shares of Revolution Medicines worth $1.8M as of Q2 2026.
  • Blackstone Inc bought 6,096 Revolution Medicines shares in Q2 2026, an estimated $890K.
  • Revolution Medicines made up 0.01% of Blackstone Inc's portfolio in Q2 2026, its #185 holding.
  • Blackstone Inc first reported a position in Revolution Medicines in Q2 2021 and has held it in 14 quarters since.
  • Blackstone Inc's Revolution Medicines position peaked at $13.2M in Q2 2021.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Blackstone Inc's 13F filing for Q2 2026, filed 14 Aug 2026.